CVS Caremark settlement could save people billions on prescriptions

AI Summary

A settlement involving CVS Caremark could potentially save billions of dollars for consumers on prescription drugs. The allegations center on the pharmacy benefit manager's preference for more expensive insulin versions to boost rebates, which has increased prices for this essential medication.

Allegations leveled against CVS Caremark accused the PBM of preferring more expensive versions of insulin in order to boost up its rebates, thus increasing prices for a lifesaving drug.